CEO selling $3.3M immediately after a weak earnings report is a strong negative signal. The cluster is 100% selling by the two most senior insiders, with no buys to offset. Monitor for further insider sales and any guidance updates. The stock may face continued selling pressure near-term.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 20 $18.81entry
- T+1 · 6mo ago +1.54%α +1.35% · $19.10
- T+5 · 6mo ago −0.64%α −1.88% · $18.69
- T+20 · 5mo ago −3.35%α −4.09% · $18.18
- T+60 · 3mo ago +37.69%α +32.69% · $25.90
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Du Ying sold $3.3M worth of ZLAB shares over a 5-day window, primarily through same-day option exercises and open-market sales, following a weak Q1 2026 earnings report (revenue down 6% YoY, net loss widened to $51M). The CLO also sold $71K. The cluster is 100% selling by the two most senior insiders, occurring 12 days after a bearish earnings release, which amplifies the negative signal.
Key Financial Metrics
Key Facts
- CEO Du Ying sold 216,231 shares for ~$3.3M in open-market sales over May 13-18, 2026.
- CLO Edmondson Frazor Titus III sold 3,517 shares for ~$71K on May 14, 2026.
- All CEO sales were same-day exercises of stock options (exercise prices $0 and $1.74), netting zero cost basis.
- Cluster occurred 12 days after Q1 2026 earnings: revenue $99.6M (-6% YoY), product revenue $95.6M (-10% YoY), net loss $51.0M.
- Total insider selling of ~$3.37M represents ~0.16% of ZLAB's $2.1B market cap.
- Cross-filing context shows cluster-insider-trades + cluster-earnings-context is an AMPLIFIER (PMI=2.50, q=0.000).
Financial Impact
CEO sold ~$3.3M, CLO sold ~$71K, total ~$3.37M (0.16% of market cap).
Risk Factors
- Further insider selling could signal deteriorating fundamentals.
- ZEJULA generic competition and widening losses may pressure the stock.
- No insider buying to provide a bullish counter-signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ZLAB-1779221970472 |
Track record
23 reports on ZLAB
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers